Edesa Biotech, Inc.

US$2.14As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:EDSAHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (34.70%)
Div yield —
ROE (122.93%)
Biotechnology
Beta (5Y) 1.24
PE TTM —
TSR TTM 15.05%
Mkt cap US$28.91M
ROIC (79.70%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.58
20.69%
(54.03%)
Hold 8|2|4|7|12
1Q26
2Q26
3Q26
4Q26
Earnings per share$
0.02
0.02
0.02
0.02
(10.76%)
(3.48%)
11.91%
12.47%
Revenue$M
2.260
2.270
2.392
2.437
9.58%
5.33%
7.41%
8.95%
Peers (US$28.91M)
Cap (US$)
PE
28.93M
—
Capital
TTM
5Y
10Y
Leveragex
0.991
0.136
0.137
EBIT/Intx
1.185
0.358
0.308
Own earn%
(11.06)
91.65
77.40
Sh yield%
42.22
35.27
31.46
Owners
Insiders/Inst%
10.01
88.12
Short interest%
5.09
SBC / revenue%
2.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
7–11
$1 testx
—
Incr. ROIC%
6